These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2687956)

  • 1. Combined modality treatment with radiotherapy and chemotherapy.
    Tannock IF
    Radiother Oncol; 1989 Oct; 16(2):83-101. PubMed ID: 2687956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of combined modality therapies for head and neck cancer.
    Dimery IW; Hong WK
    J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiation therapy in the management of gastrointestinal malignancies.
    McRee AJ; Cowherd S; Wang AZ; Goldberg RM
    Future Oncol; 2011 Mar; 7(3):409-26. PubMed ID: 21417904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity.
    Henk JM
    Clin Oncol (R Coll Radiol); 1997; 9(5):308-12. PubMed ID: 9368726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
    Argiris A; Haraf DJ; Kies MS; Vokes EE
    Oncologist; 2003; 8(4):350-60. PubMed ID: 12897332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of biochemical modulation in combined modality therapy.
    Vokes EE
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):29-33. PubMed ID: 7527598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy in non-small cell lung cancer.
    Rowell NP; O'rourke NP
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002140. PubMed ID: 15495029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
    Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
    Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
    J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy: emerging treatment improvement strategies.
    Milas L; Mason KA; Liao Z; Ang KK
    Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modalities in the treatment of head and neck cancers.
    Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.